ClinicalTrials.Veeva

Menu

Prospective Measurement of Normal Venous Sinus Pressures

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Enrolling

Conditions

Intracranial Venous Pressures

Treatments

Procedure: Venogram

Study type

Interventional

Funder types

Other

Identifiers

NCT03948971
IRB00057618

Details and patient eligibility

About

The purpose of this research is to document normal intracranial venous sinus pressures. Participants who need to have a cerebral angiogram to evaluate a medical problem not related to Idiopathic Intracranial Hypertension (IIH) will be invited to participate. Participation in this research will not require any extra visits. The intervention will take place in the interventional radiology suite when the subject has an angiogram. IIH is a condition that causes increased pressure in the brain in the absence of a tumor or other diseases that may be causing symptoms. Symptoms include headaches and visual disturbances not explained by other things. In IIH there is a narrowing in the sinuses of the brain that causes the increased pressure.

Full description

Patients will be prospectively enrolled into the study. All adult patients, aged of 18-60, determined to be candidates for elective cerebral arteriography will be screened for inclusion in this study. Patients consenting to participate and enrolled in the study will first undergo their standard cerebral angiogram procedure, as clinically indicated. Once the procedure is completed, enrolled subjects will then undergo the study intervention.

  1. Insertion of an additional catheter in the femoral vein.
  2. Navigation of the catheter into the internal jugular bulb and then catheter navigation into the superior sagittal sinus will result in additional fluoroscopic time (requires ~60 seconds of additional fluoroscopy time; carries a minimum risk of vessel perforation or other untoward event [incidence of complication associated with this procedure in the PI patient series is 0%]). There is additionally some ear pain that can happen with this Venogram.
  3. 5-10 minutes of additional procedure time. Much of this time period is merely a waiting period while the pressures stabilize and are recorded.
  4. An additional venogram injection through the catheter which exposes subjects to an additional 1-2 ml of contrast dye and 3-4 seconds of additional fluoroscopy time and its associated radiation dose.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Candidates for elective cerebral arteriography

Exclusion criteria

  • All patients with active, or a history of, intracranial venous pathology (arteriovenous malformation, arteriovenous fistulae, idiopathic intracranial hypertension, venous sinus thrombosis).
  • Patients with severe daily headaches or symptoms of idiopathic intracranial hypertension will also be excluded.
  • Body mass index > 35.
  • Known diagnosis of heart failure or pulmonary hypertension.
  • Pregnant women will be excluded due to the radiation risk associated with Angiogram and Venogram.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Venogram Group
Other group
Description:
Participants in this group have a scheduled clinically indicated a cerebral angiogram procedure and will undergo a Venogram.
Treatment:
Procedure: Venogram

Trial contacts and locations

1

Loading...

Central trial contact

Kyle Fargen, MD; Kimberly Hawley

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems